News
Molbio Diagnostics consolidated net profit declines 86.23% in the September 2026 quarter
07-Nov-2026 | 12:39
Sales decline 55.36% to Rs 259.02 crore
Net profit of Molbio Diagnostics declined 86.23% to Rs 15.12 crore in the quarter ended September 2026 as against Rs 109.80 crore during the previous quarter ended September 2025. Sales declined 55.36% to Rs 259.02 crore in the quarter ended September 2026 as against Rs 580.27 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 259.02 | 580.27 | -55 |
| OPM % | 16.97 | 28.86 | - |
| PBDT | 40.86 | 161.55 | -75 |
| PBT | 17.51 | 147.74 | -88 |
| NP | 15.12 | 109.80 | -86 |
Powered by Capital Market - Live News